SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weaker-than-expected fourth-quarter outlook, alongside slowing PC demand and supply constraints, overshadowed its better-than-expected quarterly results and drove a sharp selloff. Traders are split between calling the drop an overreaction and buying the dip, and seeing weak PC demand and bottlenecks as reasons for further pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Approaching midterms and speculation that Democrats could take control of Congress dominate discussion, with traders concerned about investigations of Trump and his businesses weighing on the Trump-linked company. Sentiment is broadly bearish, amplified by skepticism about DJTs business prospects, though some traders expect a rebound if Republicans retain control.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure amid a tech-led selloff tied to Intels weak outlook and concerns about Amazons heavy AI infrastructure spending, fueling debate over whether the AI trade is unwinding. Traders are split between expecting further declines and viewing the pullback as a buying opportunity, with volatility and support levels dominating discussion.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A tech-led selloff tied to disappointing earnings and guidance from Amazon and Intel, alongside concerns about returns on heavy AI spending, is weighing on SPY discussion. Traders are divided between expecting a deeper correction and treating the pullback as a buying opportunity.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and outlook have drawn attention after earnings and revenue missed expectations and heavy AI infrastructure spending drove free cash flow negative, prompting a sharp selloff. Traders are split: bears question the returns on spending and softer retail outlook, while bulls point to accelerating AWS growth and see the reaction as excessive.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks strong quarterly results, raised outlook and announced 8-for-1 stock split are driving discussion, but the shares fell amid a broader tech and semiconductor selloff. Many traders view the decline as an unjustified reaction to the results, while others point to profit-taking, high expectations and concerns about the AI trade and memory-cycle sustainability.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated Phase 2 lung-cancer resultsshowing an overall response rate near the prior readout but stronger activity in a small biomarker-selected subgroupsparked a sharp selloff. Traders are divided over whether the subgroup findings and planned follow-up study create a promising precision-treatment path or whether uncertain durability, regulatory timing, and a confusing management presentation cloud the NSCLC opportunity.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Reports of a major Binance exchange hack are dominating discussion as Ethereum and other cryptocurrencies sell off, alongside broader tech-market weakness and liquidations. Traders disagree over whether the exchange incident signals wider crypto risk or is isolated from Ethereum itself, with some panicking and others treating the decline as a buying opportunity.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows post-earnings selloff is centered on a weaker-than-expected outlook for contracted revenue growth and a slight earnings miss, despite revenue growth and higher AI targets. Traders are split between viewing the sharp drop as an overreaction to near-term guidance and worrying that slowing contract momentum, high expectations, or AI disruption threaten the growth story.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Semiconductor-sector pressure tied to below-expectation Microsoft and Alphabet capital spending and Samsungs profit miss is weighing on AMD; traders also debate whether Intels weak outlook signals an opportunity for AMD or broader weakness in AI-chip demand. Attention is also building around AMDs upcoming earnings, with bullish and bearish views on whether results can offset sector concerns.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Notable Wednesday Option Activity: HRTX, GLNG, KNSL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Heron Therapeutics Inc (Symbol: HRTX), where a total of 41,920 contracts have traded so far, representing approximately 4.2 million underlying shares. That amounts to ab...

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -50.00% and -11.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +14.29% and +1.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +114.29% and +18.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for July 15th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.

Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? 

Equity

The selloff highlighted the risks facing smaller companies operating in biotechnology and emerging technology. 


Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright...

Heron Therapeutics Q1 Earnings Call Highlights

Heron Therapeutics Q1 Earnings Call Highlights...

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Heron Therapeutics (HRTX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -33.33% and -3.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Heron Therapeutics Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Fulcrum shares plunged to a 52-week low of about $2.90 after the company halted development of its lead sickle cell disease drug, pociredir.</li><li>Heron shares fell to a record low of $0.44 after a federal court invalidated patents covering its cancer-supportive care drug CINVANTI.</li><li>MicroVision shares slumped after the company proposed a reverse stock split.&nbsp;</li></ul>Fulcrum Therapeutics (FULC), Heron Therapeutics (HRTX) and MicroVision (MVIS) suffered steep losses on Tuesday, with each stock falling to fresh 52-week lows as investors reacted to significant setbacks affecting their core business prospects.<a href="https://stocktwits.com/symbol/FULC">Fulcrum Therapeutics</a> and&nbsp;<a href="https://stocktwits.com/symbol/HRTX">Heron Therapeutics</a> stocks plunged by over 51% and 45%, respectively, and&nbsp;<a href="https://stocktwits.com/symbol/MVIS">MicroVision stock&nbsp;</a>slumped by nearly 32%.&nbsp;<h2 class="st-heading-2">FULC Faces Pipeline Crisis</h2>Fulcrum recorded the largest decline of the group, with shares tumbling to a 52-week low of $2.9, as the company announced on Monday that it would discontinue development of pociredir, its leading treatment candidate for sickle cell disease.The move came after the U.S. Food and Drug Administration raised concerns about possible cancer risks linked to the treatment. Since the drug was a major part of Fulcrum’s growth plans, analysts lowered their expectations for the company.&nbsp;Following the development, Fulcrum faced a wave of analyst downgrades on Tuesday. JPMorgan downgraded the stock by two levels, moving it to ‘Underweight’ from ‘Overweight’.According to JPMorgan, Fulcrum's ongoing strategic review may not be enough to offset the impact of losing its lead asset. Leerink also adopted a more cautious stance, downgrading FULC stock to ‘Market Perform’ from ‘Outperform’. The firm simultaneously slashed its price target to $4 from $24.However, on Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory.&nbsp;<h2 class="st-heading-2">Patent Setback Hits HRTX</h2>Heron also came under heavy pressure with the stock plunging to a record low of $0.44 after a federal court ruling invalidated patents tied to CINVANTI, one of the company’s important cancer-supportive care products.The ruling could allow generic versions of the drug to enter the market sooner than expected, hurting Heron’s sales. CEO Craig Collard said the company will appeal the decision.&nbsp;Following the update, Needham downgraded Heron to ‘Hold’ from ‘Buy’. Retail sentiment around the stock changed to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">MVIS Seeks Reverse Stock Split Approval&nbsp;</h2>MicroVision stock hit a 52-week low of $0.4 after the company asked its shareholders to approve a reverse stock split proposal. The proposal will be presented at the company's virtual annual shareholder meeting scheduled for July 10, where investors will vote on several measures.If successful, MicroVision's board would gain the ability to combine shares at a ratio ranging from 1-for-5 to 1-for-15. The lidar company said the measure is intended to support compliance with Nasdaq's minimum bid-price requirement. Retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;So far this year, MVIS, FULC, and HRTX stocks have plunged between 50% and 72%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/black-berry-stock-surges-overnight-cfo-ai-vision-retail-debates-meme-mania-growth-story/cZ0SpWqReDn">BlackBerry Stock Surges Overnight As CFO Stands Firm On AI Vision — Retail Debates Meme Mania Vs Growth Story</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Fulcrum Therapeutics logo is seen displayed on a smartphone screen.

Fulcrum Therapeutics (FULC), Heron Therapeutics (HRTX) and MicroVision (MVIS) suffered steep losses on Tuesday, with each stock falling to fresh 52-week lows as investors reacted to significant setbacks affecting their core business prospects.

Fulcrum Therapeutics Inc

Microvision Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.2944
Prev Close	$0.3089
Open	$0.3095
Dividend Yield	0.00%
50-Day Moving Average	$0.3286
Beta	1.43
Avg. Volume	2.16M
PE Ratio	-1.55

52-Week High	$1.58
52-Week Low	$0.261
Market Capitalization	$55.89M
EPS (Annual)	-$0.1211
Price to Book	9.52
Revenue Per Employee	$1.21M

Feed

News

Sentiment

Earnings

Fundamentals

Info

HRTX Fundamentals